Cellular Intelligence is a biotechnology company that develops engineered cell therapies, including the acquisition of a Phase 2-ready cell therapy for Parkinson's disease. The company applies cell fate engineering to advance treatments for patients.
Subscribe to see Cellular Intelligence’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cellular Intelligence is a biotech company. Xcout tracks 8 named people at Cellular Intelligence, including Arjun Raj (Chief Scientific Officer). Xcout recorded 3 job postings from Cellular Intelligence in the last 90 days, naming tools such as GitHub, Model Context Protocol.
2 more named people on record for Cellular Intelligence, with roles, board committees and tenure — see the full roster →
Xcout recorded 3 job postings from Cellular Intelligence in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Cellular Intelligence's hiring signals →
A few of Cellular Intelligence's closest competitors — see the full list of competitors and alternatives →
BlueRock Therapeutics is a clinical-stage cell therapy company headquartered in Cambridge, Massachusetts, focused on developing engineered cellular medicines for degenerative conditions.
Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.
FoldLogic Bio is a clinical-stage biotechnology company developing targeted immunotherapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. The company focuses on modulating the central nervous system's immune responses, specifically targeting microglial activity, alpha-synuclein, and TREM2 to halt disease progression.
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Neumirna Therapeutics is a biotechnology company founded in 2021 and headquartered in Copenhagen, Denmark. The firm is dedicated to pioneering RNA-based therapies to treat epilepsy, Parkinson's disease, and other neurological disorders.
NeuroInitiative is a computational biology company that uses a patented AI simulation platform to identify and prioritize drug targets for neurodegenerative and age-related diseases. The company develops therapeutic pipelines, such as its spinout Vincere Biosciences, focusing on treatments for conditions like Parkinson's disease.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Cellular Intelligence? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.